Explanipedia

Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte–Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin–Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer Open

Sam S. Chang, Karim Chamie, Eugene V. Kramolowsky, Mark L. Gonzalgo, Piyush K. Agarwal , et al. · 2025

ClinicalTrials.gov Identifier: NCT03022825.

Spatial Heterogeneity of Glomerular Phenotypes Affects Kidney Biopsy Findings Open

Jennifer A. Schaub, Christopher L. O’Connor, Meghan Dailey, Andrew W. Hlynka, Yurui Chang , et al. · 2023

Key Points Glomeruli with pathologic changes are not homogeneously distributed throughout the kidney cortex. Biopsies that do not include the kidney capsule may underdetect glomeruli with pathologic changes. Location of glomeruli with path…

Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice Open

Udit Singhal, Brent K. Hollenbeck, Samuel D. Kaffenberger, Simpa S. Salami, Arvin K. George , et al. · 2023

Our results demonstrate that the widespread alterations in prostate cancer surgery over the past 2 decades have yielded improvements in sexual, but not urinary, function recovery.

A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) Prior to Radical Prostatectomy (RP) in Locally Advanced Prostate Cancer Open

Lisa Hammer, Ralph Jiang, Jason W.D. Hearn, Robert T. Dess, Will Jackson , et al. · 2021

Prostate cancer clinical trial completion: The role of geography Open

Kristian Stensland, Samuel D. Kaffenberger, Arvin K. George, Todd M. Morgan, David C. Miller , et al. · 2021

PD08-02 NEOADJUVANT STEREOTACTIC BODY RADIOTHERAPY (SBRT) PRIOR TO RADICAL PROSTATECTOMY (RP) IN LOCALLY ADVANCED PROSTATE CANCER: A PHASE I TRIAL Open

Liat Hammer, Ralph Jiang, Jason W.D. Hearn, Robert T. Dess, Will Jackson , et al. · 2021

You have accessJournal of UrologyProstate Cancer: Localized: Radiation Therapy (PD08)1 Sep 2021PD08-02 NEOADJUVANT STEREOTACTIC BODY RADIOTHERAPY (SBRT) PRIOR TO RADICAL PROSTATECTOMY (RP) IN LOCALLY ADVANCED PROSTATE CANCER: A PHASE I TRI…

MP24-02 SATISFACTION WITH CLINICIAN-LED GERMLINE GENETIC COUNSELING IN MEN WITH PROSTATE CANCER Open

Marissa A. Solorzano, Randy Vince, Mallory Luke, Michelle F. Jacobs, Samuel D. Kaffenberger , et al. · 2021

You have accessJournal of UrologyProstate Cancer: Advanced (including Drug Therapy) II (MP24)1 Sep 2021MP24-02 SATISFACTION WITH CLINICIAN-LED GERMLINE GENETIC COUNSELING IN MEN WITH PROSTATE CANCER Marissa A. Solorzano, Randy Vince, Mallo…

MP19-06 MISMATCHES IN TRIAL LOCATION AND PROSTATE CANCER INCIDENCE: TIME TO BRING THE TRIALS TO THE PATIENTS? Open

Kristian Stensland, Samuel D. Kaffenberger, Todd M. Morgan, Randy Vince, Arvin K. George , et al. · 2021

You have accessJournal of UrologyHealth Services Research: Practice Patterns, Quality of Life and Shared Decision Making II (MP19)1 Sep 2021MP19-06 MISMATCHES IN TRIAL LOCATION AND PROSTATE CANCER INCIDENCE: TIME TO BRING THE TRIALS TO THE…

Reply by Authors Open

Juan J. Andino, Michael Sessine, Udit Singhal, Zachery R. Reichert, Daniel Wray , et al. · 2021

No AccessUrology PracticeBusiness of Urology1 Mar 2021Reply by Authorsis a reply to letterEditorial CommentEditorial Comment Juan J. Andino, Michael Sessine, Udit Singhal, Zachery R. Reichert, Daniel Wray, Christine Shafer, Marissa Moore, …

Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis Open

Daniel E. Spratt, Shawn Malone, Soumyajit Roy, Scott Grimes, Libni Eapen , et al. · 2020

PURPOSE There remains a lack of clarity regarding the influence of sequencing of androgen deprivation therapy (ADT) and radiotherapy (RT) on outcomes in prostate cancer (PCa). Herein, we evaluate the optimal sequencing of ADT with prostate…

Estimating the rate and reasons of clinical trial failure in urologic oncology Open

Kristian Stensland, Krystal DePorto, James Ryan, Samuel D. Kaffenberger, Lael Reinstatler , et al. · 2020

Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate Open

Robert T. Dess, Krithika Suresh, Michael J. Zeléfsky, Stephen J. Freedland, Brandon A. Mahal , et al. · 2020

Using a large, diverse international cohort treated with standard curative treatment options, a proposed AJCC-compliant clinical prognostic stage group system for prostate cancer has been developed. This system may allow consistency of rep…

Understanding the Barriers to Neoadjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer: A Quality Improvement Initiative Open

Juan J. Andino, Michael Sessine, Udit Singhal, Zachery R. Reichert, Daniel Wray , et al. · 2020

Despite the relatively high rates of medical oncology referral and NAC use in this cohort, there are still opportunities to improve the efficiency of this practice. Quality improvement initiatives could optimize the referral of patients wi…

Assessing Genitourinary Cancer Clinical Trial Accrual Sufficiency Using Archived Trial Data Open

Kristian Stensland, Samuel D. Kaffenberger, David Canes, Matthew D. Galsky, Ted A. Skolarus , et al. · 2020

PURPOSE Clinical trials often fail to reach their anticipated end points, most frequently because of poor accrual. Prior studies have analyzed trial termination, but it has not been easy to assess accrual estimates using international data…

Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials Open

Will Jackson, Holly Hartman, Robert T. Dess, Sam R. Birer, Payal Soni , et al. · 2020

PURPOSE In men with localized prostate cancer, the addition of androgen-deprivation therapy (ADT) or a brachytherapy boost (BT) to external beam radiotherapy (EBRT) have been shown to improve various oncologic end points. Practice patterns…

PD48-06 DETECTION OF GERMLINE MUTATIONS IN LOCALIZED AND METASTATIC PROSTATE CANCER THROUGH GUIDLINE-BASED TESTING Open

Randy Vince, Jake Quarles, Michelle F. Jacobs, Mallory Luke, Samuel D. Kaffenberger , et al. · 2020

You have accessJournal of UrologyProstate Cancer: Detection & Screening V (PD48)1 Apr 2020PD48-06 DETECTION OF GERMLINE MUTATIONS IN LOCALIZED AND METASTATIC PROSTATE CANCER THROUGH GUIDLINE-BASED TESTING Randy Vince*, Jake Quarles, Michel…

PD47-11 RAPID ORGANOID DEVELOPMENT, DRUG SCREENING, AND NEOADJUVANT CHEMOTHERAPY RESPONSE PREDICTION FOR PATIENTS WITH LOCALLY-ADVANCED BLADDER CANCER Open

Kathryn Marchetti, Nathan Merrill, Nathalie M. Vandecan, Liwei Bao, Xu Cheng , et al. · 2020

You have accessJournal of UrologyBladder Cancer: Basic Research & Pathophysiology IV (PD47)1 Apr 2020PD47-11 RAPID ORGANOID DEVELOPMENT, DRUG SCREENING, AND NEOADJUVANT CHEMOTHERAPY RESPONSE PREDICTION FOR PATIENTS WITH LOCALLY-ADVANCED BL…

Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier Open

Jeffrey J. Tosoian, Samuel R. Birer, R. Jeffrey Karnes, Jingbin Zhang, Elai Davicioni , et al. · 2020

Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature Open

Eman Abdulfatah, John M. Kennedy, Khaled Hafez, Matthew S. Davenport, Hong Xiao , et al. · 2019

Aims Renal cell carcinomas are relatively rare in children and young adults. While well characterised in adults, the morphological and molecular characterisation of these tumours in young patients is relatively lacking. The objective of th…

Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment Open

Stuart G. Silverman, Iván Pedrosa, James H. Ellis, Nicole Hindman, Nicola Schieda , et al. · 2019

Cystic renal cell carcinoma (RCC) is almost certainly overdiagnosed and overtreated. Efforts to diagnose and treat RCC at a curable stage result in many benign neoplasms and indolent cancers being resected without clear benefit. This is es…

Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer Open

Simpa S. Salami, Jeremy Kaplan, Srinivas Nallandhighal, Mandeep Takhar, Jeffrey J. Tosoian , et al. · 2019

PURPOSE Multiparametric magnetic resonance imaging (mpMRI) is used widely for prostate cancer (PCa) evaluation. Approximately 35% of aggressive tumors, however, are not visible on mpMRI. We sought to identify the molecular alterations asso…

Genetics of testicular germ cell tumors Open

Nirmish Singla, John T. Lafin, Rashed Ghandour, Samuel D. Kaffenberger, James F. Amatruda , et al. · 2019

Refinements in next-generation sequencing techniques over the last few years have enabled considerable advances in elucidating the genomic, transcriptomic, and epigenetic landscape of TGCTs. Future efforts focused on developing novel treat…

Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies Open

Will Jackson, Jéssica Silva, Holly Hartman, Robert T. Dess, Amar U. Kishan , et al. · 2019

Bladder Cancer: Non-invasive II (PD18) Open

Courtney Yong, Nathan A. Brooks, Anthony D. Oberle, Sarah Mott, Michael J. O’Donnell , et al. · 2019

You have accessJournal of UrologyBladder Cancer: Non-invasive II (PD18)1 Apr 2019Bladder Cancer: Non-invasive II (PD18) View All Author Informationhttps://doi.org/10.1097/01.JU.0000558561.73805.83AboutPDF ToolsAdd to favoritesDownload Cita…

PD18-02 INCREASED URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR D (VEGF-D) LEVELS ARE ASSOCIATED WITH RESPONSE TO COMBINED INTRAVESICAL BACILLUS CALMETTE−GUERIN (BCG) AND ORAL SUNITINIB REGIMEN FOR TREATMENT OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) Open

Colton Walker, Amir H. Lebastchi, Christopher Russell, Stephanie Daignault‐Newton, Monica Liebert , et al. · 2019

34.0%), and 19/94 (19.2%) using SB, TB, SBþTB, respectively.Downgrading at RP was observed in 9/94 (9.6%), 12/94 (12.8%), and 19/94 (20.2%) using SB, TB, and SBþTB, respectively.GG concordance was observed in 41/94 (43.6%), 50/94 (53.2%), …

MP13-08 RADIOGENOMIC DISSECTION OF MULTIFOCAL PROSTATE CANCER Open

Simpa S. Salami, Jeremy Kaplan, Srinivas Nallandhingal, Mandeep Takhar, Jeffrey J. Tosoian , et al. · 2019

You have accessJournal of UrologyProstate Cancer: Detection & Screening I (MP13)1 Apr 2019MP13-08 RADIOGENOMIC DISSECTION OF MULTIFOCAL PROSTATE CANCER Simpa Salami*, Jeremy Kaplan, Srinivas Nallandhingal, Mandeep Takhar, Jeffrey Tosoian, …

PD66-08 RETHINKING THE ONE-SIZE-FITS-MOST APPROACH TO VENOUS THROMBOEMBOLISM PROPHYLAXIS AFTER RADICAL CYSTECTOMY Open

Lauren E. Corona, Udit Singhal, Khaled Hafez, Lindsey A. Herrel, Samuel D. Kaffenberger , et al. · 2019

You have accessJournal of UrologyBladder Cancer: Epidemiology & Evaluation II (PD66)1 Apr 2019PD66-08 RETHINKING THE ONE-SIZE-FITS-MOST APPROACH TO VENOUS THROMBOEMBOLISM PROPHYLAXIS AFTER RADICAL CYSTECTOMY Lauren E Corona*, Udit Singhal,…

Bringing Prostate Cancer Germline Genetics into Clinical Practice Open

Sanjay Das, Simpa S. Salami, Daniel E. Spratt, Samuel D. Kaffenberger, Michelle F. Jacobs , et al. · 2019

Emerging evidence supports the implementation of germline genetic counseling and testing as a key component of prostate cancer management. Further research is needed to elucidate the clinical significance of lesser known germline mutations…

Prostate Cancer-Specific Mortality Following Salvage Post-Prostatectomy Radiation Therapy: A Competition Between Age and Time to Biochemical Failure Open

Will Jackson, K. Suresh, Vasu Tumati, Robert T. Dess, Payal Soni , et al. · 2018

Society of Abdominal Radiology disease-focused panel on renal cell carcinoma: update on past, current, and future goals Open

Matthew S. Davenport, Hersh Chandarana, Nicole E. Curci, Ankur M. Doshi, Samuel D. Kaffenberger , et al. · 2018

Samuel D. Kaffenberger YOU? Author Swipe